Applying in-house expertise to develop commercially relevant IP strategies

Designed to promote and facilitate investment, financing, partnerships and deal making in healthcare, Biotech and Money interviewed Barbara Fleck and Simon Bradbury for their online blog and newsletter.

The interview focuses on the application of in-house expertise when generating commercially relevant IP strategies. Barbara and Simon explain how an early focus on IP considerations can stand companies in good stead for future financing and partnering opportunities, and discuss the importance of communication in aligning IP and business goals.

To read the full article, click here.


Related posts

Eli Lilly v Genentech

Mr Justice Arnold recently handed down two judgements in the dispute between Eli Lilly and Genentech in relation to Genentech’s patent, and corresponding Supplementary Protection

Read More »